Biblio
“Nutrition: Review on the Possible Treatment for Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 3, pp. 867-883, 2018.
, “Influence of Butyrylcholinesterase in Progression of Mild Cognitive Impairment to Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1097-1105, 2018.
, “White Matter Hyperintensity Predicts the Risk of Incident Cognitive Decline in Community Dwelling Elderly.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1333-1341, 2018.
, “Characteristics of Cognitively Normal Mexican-Americans with Cognitive Complaints.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1485-1492, 2018.
, “Healthy versus Entorhinal Cortical Atrophy Identification in Asymptomatic APOE4 Carriers at Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1493-1507, 2018.
, “Biallelic Loss of Function of SORL1 in an Early Onset Alzheimer's Disease Patient.”, J Alzheimers Dis, vol. 62, no. 2, pp. 821-831, 2018.
, “Albuminuria and Microalbuminuria as Predictors of Cognitive Performance in a General Population: An 11-Year Follow-Up Study.”, J Alzheimers Dis, vol. 62, no. 2, pp. 635-648, 2018.
, “Human Gut Microbiota in Health and Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 2, pp. 549-560, 2018.
, “Designing an Internet-Based Multidomain Intervention for the Prevention of Cardiovascular Disease and Cognitive Impairment in Older Adults: The HATICE Trial.”, J Alzheimers Dis, vol. 62, no. 2, pp. 649-663, 2018.
, “Perspectives on Communicating Biomarker-Based Assessments of Alzheimer's Disease to Cognitively Healthy Individuals.”, J Alzheimers Dis, vol. 62, no. 2, pp. 487-498, 2018.
, “Homocysteine and Cerebral Atrophy: The Epidemiology of Dementia in Singapore Study.”, J Alzheimers Dis, vol. 62, no. 2, pp. 877-885, 2018.
, “Visit-To-Visit Blood Pressure Variability and the Risk of Dementia in Older People.”, J Alzheimers Dis, vol. 62, no. 2, pp. 727-735, 2018.
, “Interactions between Atrial Fibrillation, Cardiovascular Risk Factors, and ApoE Genotype in Promoting Cognitive Decline in Patients with Alzheimer's Disease: A Prospective Cohort Study.”, J Alzheimers Dis, vol. 62, no. 2, pp. 713-725, 2018.
, “Homocysteine and Dementia: An International Consensus Statement.”, J Alzheimers Dis, vol. 62, no. 2, pp. 561-570, 2018.
, “Death Rate Due to COVID-19 in Alzheimer's Disease and Frontotemporal Dementia.”, J Alzheimers Dis, vol. 78, no. 2, pp. 537-541, 2020.
, “Could Altered Evoked Pain Responsiveness Be a Phenotypic Biomarker for Alzheimer's Disease Risk? A Cross-Sectional Analysis of Cognitively Healthy Individuals.”, J Alzheimers Dis, vol. 79, no. 3, pp. 1227-1233, 2021.
, “Broader Insights into Understanding Tumor Necrosis Factor and Neurodegenerative Disease Pathogenesis Infer New Therapeutic Approaches.”, J Alzheimers Dis, vol. 79, no. 3, pp. 931-948, 2021.
, “Diabetic Retinopathy Predicts Risk of Alzheimer's Disease: A Danish Registry-Based Nationwide Cohort Study.”, J Alzheimers Dis, vol. 86, no. 1, pp. 451-460, 2022.
, “Post-Stroke Cognitive Impairment: Epidemiology, Risk Factors, and Management.”, J Alzheimers Dis, vol. 86, no. 3, pp. 983-999, 2022.
, “Investigating Casual Associations Among Gut Microbiota, Metabolites, and Neurodegenerative Diseases: A Mendelian Randomization Study.”, J Alzheimers Dis, vol. 87, no. 1, pp. 211-222, 2022.
, “Investigating Causal Relations Between Circulating Metabolites and Alzheimer's Disease: A Mendelian Randomization Study.”, J Alzheimers Dis, vol. 87, no. 1, pp. 463-477, 2022.
, “Avoiding Over-Reliance on Multi-Domain Interventions for Dementia Prevention.”, J Alzheimers Dis, vol. 90, no. 3, pp. 989-992, 2022.
, “COVID-19 as a Risk Factor for Alzheimer's Disease.”, J Alzheimers Dis, vol. 91, no. 1, pp. 1-23, 2023.
, “Association Between Oral Bacteria and Alzheimer's Disease: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 91, no. 1, pp. 129-150, 2023.
, “Poor Oral Health as a Risk Factor for Dementia in a Swedish Population: A Cohort Study with 40 Years of Follow-Up.”, J Alzheimers Dis, vol. 92, no. 1, pp. 171-181, 2023.
,